Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Clinical trial NCT03439462 · COMPLETED
Trial details
- NCT number
- NCT03439462
- Sponsor
- Aadi Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2022-08-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.